For decades, biopharma executives have seen operational costs and complexities soar. As commercial pricing, reimbursement, and market access hurdles remain particularly difficult to overcome, CEOs are ...
In my previous article, I made three important arguments about leaders’ efforts and responsibility to enhance the justice, equity, diversity and inclusion (JEDI) of their work and impact in their ...
As 2020 ends, it is a good time to set forth your learning plans for 2021 and beyond. The Talent Capability Model is a great tool for identifying current knowledge and skills gaps—and prioritizing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results